Xinlu Lin

机构：Wenzhou Medical University, Second Affiliated Hospital & Yuying Children's Hospital of Wenzhou Medical University, Taizhou First People's Hospital · ORCID：0000-0002-0637-9440

发表论文 13 篇 · 总被引 331 次 · h-index 8

代表论文

• Tumor Microenvironment-Responsive, Multistaged Liposome Induces Apoptosis and Ferroptosis by Amplifying Oxidative Stress for Enhanced Cancer Therapy (2020 · ACS Applied Materials & Interfaces · 被引 74)
• Dual-targeting celecoxib nanoparticles protect intestinal epithelium and regulate macrophage polarization for ulcerative colitis treatment (2022 · Chemical Engineering Journal · 被引 51)
• The role of transporters in cancer redox homeostasis and cross-talk with nanomedicines (2020 · Asian Journal of Pharmaceutical Sciences · 被引 44)
• Endocytosis of ATB 0,+ (SLC6A14)-targeted liposomes for drug delivery and its therapeutic application for pancreatic cancer (2020 · Expert Opinion on Drug Delivery · 被引 37)
• Bilirubin ameliorates osteoarthritis via activating Nrf2/HO‐1 pathway and suppressing NF‐κB signalling (2024 · Journal of Cellular and Molecular Medicine · 被引 35)
• Nanoparticle mediated codelivery of nifuratel and doxorubicin for synergistic anticancer therapy through STAT3 inhibition (2020 · Colloids and Surfaces B Biointerfaces · 被引 35)